Imbornoni Lauren Marie, McGhee Charles Ninian John, Belin Michael Wellington
Department of Ophthalmology and Vision Science, University of Arizona, United States.
Department of Ophthalmology, The University of Auckland, Auckland, New Zealand.
Klin Monbl Augenheilkd. 2018 Jun;235(6):680-688. doi: 10.1055/s-0044-100617. Epub 2018 Apr 26.
This review describes the evolution of the diagnosis and treatment of keratoconus from the earliest written description to present day. The first description was provided in 1736 by Benedict Duddell who described the prominent corneas of a fourteen-year-old boy. Throughout the 19th century, a variety of surgical procedures were proposed to manage the disease, such as surgically repositioning the pupil away from the cone, iris incarceration to produce a slit-like pupil, cauterization of the cone to produce a scar, and full thickness elliptical excision of the cone. Despite the ingenuity of these procedures, many led to serious complications. In 1936, Ramon Castroviejo revolutionized surgical management by performing the first corneal transplant for keratoconus. The advent of refractive surgery in the 1990s brought about a sudden and critical need for better understanding of keratoconus and corneal ectatic disease. Topographic analysis allowed for earlier detection of keratoconus, prior to clinical signs and symptoms. Tomographic analysis provided analysis of the anterior and posterior surfaces of the cornea and allowed for even earlier detection. The Belin/Ambrosio Enhanced Ectasia Display on the Pentacam incorporates anterior and posterior elevation, pachymetric map, best fit sphere and enhanced reference surface to provide an overall "D" value that is predictive of ectatic disease. This display allows refractive providers to quickly and accurately screen potential refractive surgery candidates to identify those at risk for ectasia and early subclinical keratoconus. Corneal crosslinking was revolutionary in the treatment of keratoconus. There have been several randomized controlled trials that have found it to be safe and effective to halt ectatic progression. Crosslinking was recently approved by the FDA for progressive keratoconus. Currently, there is no clear definition of ectasia progression. Providers must be able to clearly, objectively and consistently diagnose progressive disease to institute timely treatment in the population with the greatest potential benefit. The new Belin ABCD grading system and progression analysis incorporated into the Oculus Pentacam software provides an objective way of assessing progression over time. Keratoconus diagnosis and management have grown tremendously since the first description in 1736, but there is still much to learn about keratoconus and its management.
这篇综述描述了圆锥角膜诊断和治疗方法从最早的文字记载到当今的演变历程。首次描述是在1736年由本尼迪克特·达德尔做出的,他描述了一名14岁男孩突出的角膜。在整个19世纪,人们提出了各种手术方法来治疗这种疾病,比如通过手术将瞳孔从圆锥区重新定位、虹膜嵌顿以形成裂隙状瞳孔、烧灼圆锥区以形成瘢痕,以及对圆锥区进行全层椭圆形切除。尽管这些手术方法独具匠心,但许多都导致了严重的并发症。1936年,拉蒙·卡斯特罗维霍通过为圆锥角膜患者实施首例角膜移植手术,彻底改变了手术治疗方式。20世纪90年代屈光手术的出现,突然且迫切地需要人们更好地了解圆锥角膜和角膜扩张性疾病。地形图分析能够在临床体征和症状出现之前更早地检测出圆锥角膜。断层扫描分析提供了角膜前表面和后表面分析,能实现更早的检测。Pentacam上的贝林/安布罗西奥增强型扩张显示整合了前后高度、角膜厚度图、最佳拟合球镜和增强参考面,以提供一个预测扩张性疾病的总体“D”值。这种显示使屈光手术医生能够快速、准确地筛查潜在的屈光手术候选者,以识别那些有扩张风险和早期亚临床圆锥角膜的人。角膜交联在圆锥角膜治疗方面具有革命性意义。有几项随机对照试验发现,它在阻止扩张进展方面是安全有效的。交联最近被美国食品药品监督管理局批准用于进行性圆锥角膜。目前,对于扩张进展尚无明确的定义。医疗人员必须能够清晰、客观且一致地诊断进行性疾病,以便在最有可能受益的人群中及时开展治疗。纳入Oculus Pentacam软件的新贝林ABCD分级系统和进展分析提供了一种客观评估随时间进展情况的方法。自1736年首次描述以来,圆锥角膜的诊断和治疗有了巨大发展,但关于圆锥角膜及其治疗仍有许多有待了解之处。